Topics

Latest "Incyte Corporation Incyte Corporation" News Stories

03:48 EST 24th February 2020 | BioPortfolio

Here are the most relevant search results for "Incyte Corporation Incyte Corporation" found in our extensive news archives from over 250 global news sources.

More Information about Incyte Corporation Incyte Corporation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Incyte Corporation Incyte Corporation for you to read. Along with our medical data and news we also list Incyte Corporation Incyte Corporation Clinical Trials, which are updated daily. BioPortfolio also has a large database of Incyte Corporation Incyte Corporation Companies for you to search.

Showing "Incyte Corporation Incyte Corporation" News Articles 1–25 of 237

Extremely Relevant

Lilly and Incyte Announce Positive Top-Line Results from the North American Phase 3 Study (BREEZE-AD5) of Oral Selective JAK Inhibitor Baricitinib in Patients with Moderate- to Severe Atopic Dermatitis

Study met the primary endpoint of at least 75% improvement of skin inflammation and key secondary endpointsSafety profile was consistent with the known safety findings of baricitinib in atopic dermatitisResults from this study conducted in North America continue to support regulatory submissions TORONTO, Feb. 11, 2020 (GLOBE NEWSWIRE) -- Eli Lilly and Company and Incyte announced that ba...


IRADIMED CORPORATION to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference

WINTER SPRINGS, Fla., Aug. 27, 2019 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (NASDAQ: IRMD), today announced that Leslie McDonnell, President and Chief Executive Officer, Roger Susi, Chairman and Chief Technology Officer and Chris Scott, Chief Financial Officer, will participate in the … Continue reading →

Composition of the Nomination Committee of Orion Corporation

ORION CORPORATION     STOCK EXCHANGE RELEASE   28 OCTOBER 2019 at 19.30 EET Composition of the Nomination Committee of Orion Corporation The Board of Directors of Orion Corporation has elected the following persons to the Nomination Committee of the company: Annika EkmanErkki EtolaPetteri KarttunenMatti KavetvuoTimo MaasiltaHeikki WesterlundJukka Ylppö Heikki Westerlund was elect...


Orion Corporation: Managers’ transactions – Agendum Oy

ORION CORPORATION      MANAGERS’ TRANSACTIONS 09 December 2019 at 10.30 EET Orion Corporation: Managers’ transactions – Agendum Oy Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. Person su...

Orion Corporation: Managers’ transactions – Sydäntutkimussäätiö sr.

ORION CORPORATION      MANAGERS’ TRANSACTIONS 13 December 2019 at 15.15 EET Orion Corporation: Managers’ transactions – Sydäntutkimussäätiö sr. Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated p...

Notice to the Annual General Meeting of Orion Corporation

ORION CORPORATION         STOCK EXCHANGE RELEASE     5 FEBRUARY 2020 at 12:15 EET              Notice to the Annual General Meeting of Orion Corporation Notice is given to the shareholders of Orion Corporation to the Annual General Meeting to be held on Wednesday 25 March 2020 at 2:00 p.m. Finnish time in Messukeskus Helsinki, Exhibition and Convention Centre, ...

Orion Corporation: Managers’ transactions – Timo Lappalainen

ORION CORPORATION      MANAGERS’ TRANSACTIONS 19 July 2019 at 13.15 EETS Orion Corporation: Managers’ transactions – Timo Lappalainen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. Pe...

PDS Biotechnology Corporation Announces Closing of Public Offering

PRINCETON, N.J., Feb. 14, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immuno-oncology company developing multiple therapies based on the Company’s proprietary Versamune® T-cell activating technology, today announced the closing of its previously announced underwritten public offering of 9,230,770 shares of common stock at a public offering pr...

Orion Corporation: Managers’ transactions – Mikael Silvennoinen

ORION CORPORATION      MANAGERS’ TRANSACTIONS 9 December 2019 at 10.45 EET Orion Corporation: Managers’ transactions – Mikael Silvennoinen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. Pe...

Relevant

Orion Corporation's financial reporting and Annual General Meeting in 2020

ORION CORPORATION          STOCK EXCHANGE RELEASE           17 JULY 2019 at 11.00 a.m. EEST                       Orion Corporation's financial reporting and Annual General Meeting in 2020   Orion Corporation will publish its Financial Statement Release 2019 on Wednesday, 5 February 2020. The publication dates of the Interim Reports and the Half-Year Fi...

Adaptive Biotechnologies Corporation Reports Second Quarter 2019 Financial Results

SEATTLE, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT) today reported financial results for the quarter ended June 30, 2019. “At Adaptive, we are translating the genetics of the adaptive immune system into clinical products to transform the diagnosis and treatment of disease,” said Chad Robins, chief executive offic...

Cambium Networks Corporation Announces Third Quarter 2019 Reporting Date

ROLLING MEADOWS, Ill., Oct. 23, 2019 (GLOBE NEWSWIRE) -- Cambium Networks Corporation (“Cambium Networks”) (NASDAQ: CMBM), a leading provider of wireless broadband networking infrastructure solutions, today announced that it plans to report financial results for the third quarter 2019 ended September 30, 2019 on Thursday, November 7, 2019. Cambium Networks will host a webcast and con...

Cambrex Corporation Announces Expiration of “Go Shop” Period Under Merger Agreement

EAST RUTHERFORD, N.J., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM) (the “Company” or “Cambrex”) today announced the expiration, as of 12:01 a.m., Eastern Time, on September 22, 2019, of the 45-day “go shop” period under the previously announced Agreement and Plan of Merger, dated as of August 7, 2019 (the “Merger Agreement”), which provides for the C...

Adaptive Biotechnologies Corporation Reports Third Quarter 2019 Financial Results

SEATTLE, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT) today reported financial results for the quarter ended September 30, 2019. “During the third quarter, we continued to make strong progress across our existing products and our pipeline,” said Chad Robins, chief executive officer and co-founder of Adaptive. ...

Geron Corporation Reports Second Quarter 2019 Financial Results and Recent Events

MENLO PARK, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the second quarter ended June 30, 2019, and recent events. The Company ended the second quarter with $162.3 million in cash and marketable securities. During the second quarter, data from the Phase 2 portion of IMerge was reported at the European Hematology Association (...

ContraFect Corporation Prices Approximately $10 Million Public Offering of Common Stock

YONKERS, N.Y., Dec. 17, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on discovering and developing direct lytic agents for the treatment of life-threatening infectious diseases, today announced the pricing of its underwritten public offering of 25,650,000 shares of its common stock at a public offering price of $0.39 per sh...

Recommendation by the Nomination Committee concerning the Board of Directors to be elected by the 2020 AGM of Orion Corporation

ORION CORPORATION  STOCK EXCHANGE RELEASE 22 JANUARY 2020 at 12.45 EET          Recommendation by the Nomination Committee concerning the Board of Directors to be elected by the 2020 AGM of Orion Corporation The Nomination Committee of Orion Corporation has on 22 January 2020 given to the company’s Board of Directors its recommendation for the proposal to the Annual General Mee...

Geron Corporation Reports Third Quarter 2019 Financial Results and Recent Events

MENLO PARK, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the third quarter and year-to-date as of September 30, 2019 as well as recent events. The Company ended the third quarter with $159.3 million in cash and marketable securities. “Geron has continued to execute on its 2019 development plans,” said John A. Scarlett...

Cambium Networks Corporation Announces Second Quarter Fiscal 2019 Reporting Date

ROLLING MEADOWS, Ill., July 29, 2019 (GLOBE NEWSWIRE) -- Cambium Networks Corporation (“Cambium”) (NASDAQ: CMBM), a leading provider of wireless broadband networking infrastructure solutions, today announced that it plans to report financial results for the second quarter of fiscal 2019 ended June 30, 2019 on Thursday, August 8, 2019. Cambium will host a webcast and conference call to dis...

Arrayit Corporation Approved as New Medicare Part B Healthcare Provider for Allergy Testing Services

Sunnyvale, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, has been approved by a leading Medicare Administrative Contractor (MAC) on behalf of the Centers for Medicare and Medicaid Services (CMS) as a new allergy testing services healthcare provider for Medicare Part B. Medicare Part B covers medically necessary services ...

AgraFlora Organics International Inc. Announces Intention to Launch Takeover Bid for Eviana Health Corporation

Offer valued at C$0.50 per Eviana share49.25% premium to Eviana’s closing price on August 9, 2019 VANCOUVER, British Columbia, Aug. 09, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc.  (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, announces that it intends to make an...

Arrayit Corporation Announces Allergy Testing Services Network Expansion to Multiple Clinics in Hawaii

Sunnyvale, July 15, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, has expanded its national allergy testing services network to include several new clinics in the State of Hawaii, adding to the well over 700 clinics in North America and bolstering the company’s presence in the Pacific. As the 50thstate, Hawaii’s 1.4 million res...

Cambium Networks Corporation Announces Fourth Quarter and Full Year 2019 Reporting Date

ROLLING MEADOWS, Ill., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Cambium Networks Corporation (“Cambium Networks”) (NASDAQ: CMBM), a leading provider of wireless broadband networking infrastructure solutions, today announced that it plans to report financial results for the fourth quarter and full year 2019 ended December 31, 2019 on Monday, February 10, 2020. Cambium Networks will host a we...

PDS Biotechnology Corporation Announces Pricing of Public Offering of Approximately $12 Million of Shares of Common Stock

PRINCETON, N.J., Feb. 11, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (“PDS Biotechnology”) (Nasdaq: PDSB), a clinical-stage immuno-oncology company developing multiple therapies based on PDS Biotechnology’s proprietary Versamune® T-cell activating technology, today announced the pricing of an underwritten public offering consisting of 9,230,770 shares of common stock at...

AdvanSource Biomaterials Corporation Announces Completion of the Sale of Substantially All of its Assets to a Subsidiary of Mitsubishi Chemical America

WILMINGTON, Mass, Feb. 03, 2020 (GLOBE NEWSWIRE) --  AdvanSource Biomaterials Corporation (OTC: ASNB) (“AdvanSource” or the “Company”), a materials technology company specializing in medical grade polymers for long and short term applications, announced today that on Friday, January 31, 2020, substantially all of its assets were sold to Mitsubishi Chemical Performance Polymers, I...


Quick Search

News Quicklinks